Please use this identifier to cite or link to this item:
http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13528
Title: | Phloretin as an add-on therapy to losartan attenuates diabetes-induced AKI in rats: A potential therapeutic approach targeting TLR4-induced inflammation |
Authors: | Gaikwad, Anil Bhanudas |
Keywords: | Pharmacy Inflammation Phloretin Toll-like receptor-4 (TLR4) Diabetes Acute Kidney Injury (AKI) |
Issue Date: | Nov-2023 |
Publisher: | Elsevier |
Abstract: | Targeting Toll-like receptor 4 (TLR4) and Angiotensin II type 1 receptor (AT1R) could provide renoprotection during acute kidney injury (AKI) mainly by regulating inflammation, oxidative stress, mitochondrial dysfunction, and apoptosis. Phloretin (TLR4 inhibitor) as an add-on therapy to losartan (AT1R inhibitor) could provide more therapeutic benefits against AKI under diabetic condition. We aimed to study the effect of phloretin as an add-on therapy to losartan against AKI under diabetic condition. |
URI: | https://www.sciencedirect.com/science/article/pii/S0024320523007300 http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13528 |
Appears in Collections: | Department of Pharmacy |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.